Operating Income (Loss) in USD of Phathom Pharmaceuticals, Inc. from Q1 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2018 to Q3 2025.
  • Phathom Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$15.3M, a 78.4% increase year-over-year.
  • Phathom Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$213M, a 25.9% increase year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Operating Income (Loss) for 2024 was -$277M, a 65.8% decline from 2023.
  • Phathom Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$167M, a 2.97% increase from 2022.
  • Phathom Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$172M, a 27.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Phathom Pharmaceuticals, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$213M -$15.3M +$55.5M +78.4% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 -$269M -$59.9M +$17.4M +22.5% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$286M -$78.9M -$8.91M -12.7% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 -$277M -$59.4M +$10.5M +15% 01 Oct 2024 31 Dec 2024 10-K 06 Mar 2025
Q3 2024 -$288M -$70.8M -$35.1M -98.5% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 -$253M -$77.3M -$45.6M -144% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$207M -$70M -$39.9M -133% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 -$167M -$69.9M -$23.2M -49.8% 01 Oct 2023 31 Dec 2023 10-K 06 Mar 2025
Q3 2023 -$144M -$35.7M +$6.87M +16.2% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$151M -$31.7M +$13.7M +30.1% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$165M -$30.1M +$7.83M +20.7% 01 Jan 2023 31 Mar 2023 10-Q/A 14 Jun 2024
Q4 2022 -$172M -$46.6M -$13.6M -41.2% 01 Oct 2022 31 Dec 2022 10-K/A 14 Jun 2024
Q3 2022 -$159M -$42.5M -$9.39M -28.3% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$149M -$45.4M -$10M -28.4% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$139M -$37.9M -$4.32M -12.9% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q4 2021 -$135M -$33M +$19.4M +37% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2023
Q3 2021 -$154M -$33.1M -$307K -0.94% 01 Jul 2021 30 Sep 2021 10-Q/A 09 Nov 2022
Q2 2021 -$154M -$35.3M -$15.3M -76.4% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022
Q1 2021 -$139M -$33.6M -$13.2M -64.8% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 -$126M -$52.4M -$36.7M -234% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2021
Q3 2020 -$88.9M -$32.8M -$26.5M -423% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 -$62.4M -$20M +$63M +75.9% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021
Q1 2020 -$125M -$20.4M -$19.1M -1562% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q4 2019 -$106M -$15.7M -$15.2M -3380% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2021
Q3 2019 -$91M -$6.28M -$6.01M -2244% 01 Jul 2019 30 Sep 2019 10-K 30 Mar 2021
Q2 2019 -$85M -$83M -$82.8M -32455% 01 Apr 2019 30 Jun 2019 10-K 30 Mar 2021
Q1 2019 -$2.2M -$1.23M -$975K -388% 01 Jan 2019 31 Mar 2019 10-K 30 Mar 2021
Q4 2018 -$1.23M -$451K 01 Oct 2018 31 Dec 2018 10-K 19 Mar 2020
Q3 2018 -$268K 01 Jul 2018 30 Sep 2018 10-K 19 Mar 2020
Q2 2018 -$255K 01 Apr 2018 30 Jun 2018 10-K 19 Mar 2020
Q1 2018 -$251K 01 Jan 2018 31 Mar 2018 10-K 19 Mar 2020

Phathom Pharmaceuticals, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$277M -$110M -65.8% 01 Jan 2024 31 Dec 2024 10-K 06 Mar 2025
2023 -$167M +$5.13M +2.97% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2025
2022 -$172M -$37.4M -27.7% 01 Jan 2022 31 Dec 2022 10-K/A 14 Jun 2024
2021 -$135M -$9.42M -7.49% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2023
2020 -$126M -$19.5M -18.3% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022
2019 -$106M -$105M -8571% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021
2018 -$1.23M 01 Jan 2018 31 Dec 2018 10-K 19 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.